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Abstract  
 
Recently Fenton (2009) has argued that Buddhist ethics can accommodate the use of 
attention-enhancing drugs and Walker (2006, 2009) has argued that future 
neurotechnologies may be used to enhance happiness and virtue. This paper uses a 
Western Buddhist perspective, drawing on many Buddhist traditions, to explore how 
emerging neurotechnologies may be used to suppress vices and enhance happiness and 
virtue. A Buddhist approach to the authenticity of technologically-mediated spiritual 
progress is discussed. The potential utility and dangers of mood manipulation for a 
Buddhist understanding of liberation are outlined. Then the ten paramitas of Theravadan 
Buddhism are explored to frame an exploration of the potential genes, neurochemicals 
and brain structures that could be targeted as part of a program of neurotechnological 
moral enhancement. 
 
Introduction: Buddhism, Virtue and Moral Enhancement 
 
In “Buddhism and Neuroethics” Andrew Fenton (2009) argues that the use of 
methylphenidate (Ritalin) as an aid to daily mindfulness could be consistent with 
Buddhist ethics. Fenton notes that Mahayana Buddhism is especially open to the 
utilitarian rationale that something like a drug might be a “skillful means” to greater 
concentration and attentiveness to one’s life. In this essay I will expand Fenton’s 
argument to argue that Buddhists may use a variety of future neurotechnologies to 
enhance not just mindfulness but also happiness and virtue.  The essay attempts to offer a 
specifically Buddhist perspective on arguments for moral enhancement or “virtue 
engineering” recently offered by a number of philosophers (principally Walker, 2009; as 
well as to  Spence, 2008; Faust, 2008; Douglas, 2008; Persson and Savulescu, 2008; 
Savulescu and Persson, 2012).  
 
The arguments made here are also specifically a modern, Western interpretation of 
Buddhism which borrows freely from the Theravadan, Mahayana, Tantric and Zen 
traditions, as do many Western Buddhist teachers and communities. The key ideas 
presented are consistent with most Buddhist traditions, with minor adjustments of 
terminology, but I will also attempt to acknowledge where there are relevant significant 
differences between Buddhist traditions. 
 
The cultivation of virtuous thoughts, sentiments and action is central to all Buddhist 
traditions. But there is a lively ongoing debate about whether the Buddhist emphasis on 
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the importance of cultivating virtue means that Buddhist ethics are a form of virtue 
ethics. Damien Keown (1992) and James Whitehill (1994) have argued that, among the 
moral theories of the West, Buddhist ethics most closely resembles Aristotleian virtue 
ethics.  Siderits (2003) and Goodman (2008,2009) have argued, on the other hand, that 
Buddhist ethics is a form of consequentialism (Siderits, 2003; Goodman, 2008, 2009), 
since the enlightened being is supposed to have transcended individual identity and be 
motivated solely by the needs of all sentient beings.  
 
In my view the Buddhist tradition embodies both of these forms of ethics in a 
developmental trajectory of spiritual development. The ethics enjoined for most lay 
Buddhists in Asian societies, householders who do not have the opportunity to pursue 
enlightenment, is focused on the cultivation of virtue in order to ensure a good rebirth. 
The core of lay virtue is the observance of the pancasila or five ethical observances: not 
to kill, lie, steal, take intoxicants or practice sexual misconduct. If these virtuous practices 
are observed laypeople may be reborn in heavenly realms instead of as ghosts or in hells. 
This has been called kammic ethics to distinguish it from the nibbanic ethics practiced by 
monks, nuns and the extraordinary laity who are trying to achieve Enlightenment (King, 
1964; Spiro, 1972).  Although inconsistent with canonical Buddhist teachings, many 
Buddhist laity also believe that the good karma or merit accrued by monastics in their 
cultivation of virtue can be dedicated or transferred to lay people when they support 
monastics, or give dana.  
 
The second stage of virtuous practice applies to the aspirants after Enlightenment.  So 
long as an individual suffers under the illusion of self, with its attendant greed, hatred and 
ignorance, then all Buddhist traditions advise that the cultivation of virtue is necessary for 
spiritual progress.  The canonical formula is found in the Four Noble Truths articulated in 
what Theravadans say was the Buddhas first sermon, the "Turning of the Wheel of the 
Dharma" Sutra. (1) Life is full of unease and dissatisfaction because (2) we are constantly 
grasping and craving. (3) In order to stop grasping and craving we need to (4) develop a 
skillful, virtuous life based on the Eightfold Path: right views, right intentions, right 
speech, right action, right livelihood, right effort, right mindfulness and right 
concentration.    
 
The Pali canon’s Buddhavamsa, part of the Khuddaka Nikaya Sutta (Dhammapala, 1978) 
offers a different list of virtues, the "perfections" or paramis of the Buddhas which I will 
use to structure this essay : 
 
Dana - generosity 
Sila - proper conduct 
Nekkhamma - renunciation 
Prajna - transcendental wisdom, insight 
Virya - energy, diligence, vigor, effort 
Kshanti - patience, tolerance, forbearance, acceptance, endurance 
Sacca - truthfulness, honesty 
Adhitthana - determination, resolution 
Metta - loving-kindness 
Upekkha -  equanimity, serenity 
 
This formulation of the virtues was presented in the Theravada texts as the perfections of 
the bodhisattva who would later become the Buddha. The paramitas provide a bridge 
between the Theravadan tradition, in which the soteriological goal is to become an arhat, 
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and stop reincarnating, and most Mahayana traditions in which the soteriological goal is 
become a bodhisattva and stay in world after Enlightenment to help all sentient beings. 
While the paramitas were part of the hagiography of the Buddha in the Theravadan text, 
they became (in varying forms) the central list of virtues to practice for Mahayanists.  
 
Once Enlightenment is achieved, in both the Theravadan and Mahayana accounts, the 
cultivation of virtue becomes irrelevant. The enlightened person has no vices to avoid, no 
cravings or bad habits to suppress. They act out of selfless compassion for all beings as 
pure consequentialists. Until that point, for the vast majority of Buddhists however, the 
cultivation of mental and behavioral virtue is central. 
 
Moral	Enhancement	
 
The Buddhist tradition recognizes that we are not all born with equal propensities 
to wisdom or moral behavior, and that Enlightenment is only possible for the 
very few.  In "Cognitive Enhancement, Virtue Ethics and the Good Life," Barbro 
Fröding (2011) concludes that a fully virtuous life is biologically impossible for 
most people.  But, given the rapid advance of neurotechnologies, "if these 
cognitive shortcomings could be compensated for, or balanced, through the use 
of safe and voluntary enhancement techniques, then it would be morally desirable 
to do so. Indeed, it could well be the case that a combination of cognitive 
enhancement and virtue could make virtue ethics more convincing."  If specific, 
consistent moral behavioral orientations – truthfulness, compassion and so on – 
can be identified, and our likelihood of manifesting them is strongly influenced 
by inherited genetic predispositions or persistent neurochemistry, then it might be 
possible to use future neurotechnologies to systematically make ourselves more 
truthful or compassionate. The use of neurotechnologies to consistently avoid 
vices and practice virtues would be useful in cleansing the mind of klesas or 
mental impurities. 
 
The widely held belief that people have moral character - consistently good or 
bad moral predilections across diverse situations - has recently been called into 
question by the “situationist” school of social psychologists (Doris, 2002; 
Harman, 1999). While personality psychologists can point to some consistency of 
moral behavior across time and between situations, the situationists can point to 
people being compassionate in some circumstances but greedy, selfish and cruel 
in others.   
 
Fortunately the project of technologically enhancing virtue does not really 
require a strong theory of “moral character” or even the existence of virtuous 
moral traits. Even if individuals are strongly primed to be compassionate by 
specific environmental cues, and less so in other situations their compassion is 
still neurochemically mediated and could still be neurochemically enhanced. In 
other words, even if someone was only compassionate while taking a compassion 
drug, like a diabetic’s dependence on insulin, it would still be possible to 
systematically enhance their compassion.  
 
A second question that is sometimes raised about the use of neurotechnology to 
achieve “spiritual” ends is whether the result would be “authentic.” Sometimes a 
distinction is made between praise-worthy “natural” methods of self-
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transformation, and “unnatural” methods. But which is more natural, gossiping 
around the fire or sitting silently for hours, having visions in a sweat lodge, and 
taking peyote? In other words taking a drug to control one’s cravings or sharpen 
one’s mind is no more or less natural for homo sapiens than many spiritual 
practices. 
 
A concern with authenticity is also inconsistent with the central Buddhist insight 
of annatta, that there is no “authentic self,” no enduring, consistent soul or self-
essence. Since there is no self the medicated person is no more or less authentic. 
The only question is whether they are better able to deal with the demands of 
their life and make spiritual progress.  
 
The concern with authenticity also reflects a concern with how similar the results 
would be from spiritual exercises as opposed to neurotechnologies. If chemically 
enhancing compassion, persistence or discernment only lasts for the drug’s half 
life, while participation in religious community and meditation effect lasting 
behavioral and cognitive changes, then the former would be at best be an adjunct 
to the latter. In that case moral enhancement drugs might speed the development 
of virtues as an adjunct to a program of self-reform, and act as a stopgap to 
prevent backsliding in especially trying circumstances.   
 
So long as the neurotechnologies are drugs they may be restricted to being a 
temporary adjunct rather than the principal method of self-improvement. But 
eventually we will have the capacity to change genes that affect the brain 
permanently, and install neurodevices that constantly monitor and direct our 
thoughts and behavior. At that point the distinction between traditional methods 
of self-change and neurotechnology may become moot. In fact, eventually it is 
quite likely that the changes of thought and behavior that neurotechnology will 
enable will be much quicker, far surer, longer-lasting and more targeted than 
traditional religious practices. 
 
Chemical Happiness 
 
Buddhist psychology advises that the practice of these virtues will replace predilections 
to do wrong with a joy in doing and being good, similar to Aristotle’s theory of 
eudaemonic happiness achieved though virtuous behavior.  If the soteriological goal of 
Buddhism is to alleviate one’s own suffering, and the perfection of virtue is merely a tool 
to that end, is it possible to skip the enhancement of virtue and just use neurotechnology 
to eliminate suffering? 
 
Both lay and monastic Buddhist precepts include a vow to abstain from intoxicants. In 
ancient India the principal concern would have been with alcohol. This is not an absolute 
prohibition since the medicinal use of intoxicants are explicitly permitted for monks in 
the Vinaya, the code of monastic conduct. Whether other substances, such as caffeine, 
tobacco and psychedelics, should be considered intoxicants by Buddhists has also been 
debated (Redmond, 2004). The key question is whether the drug intoxicates, creating 
stupefaction and chemical pleasure that delays efforts to eliminate dukkha, the unease 
that is starting point for realizing the unsatisfactory nature of grasping self-centered 
existence. While alcohol, opiates and cannabis certainly could not create a permanent 
state chemical happiness, much less facilitate spiritual insight, the neurotechnologies of 
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this century might create permanent changes of mood. Therefore a Buddhist approach to 
cognitive enhancement would first distinguish between the use of neurotechnologies that 
is intoxicating, use that is temporarily therapeutic, and use that enables long-term 
spiritual progress. 
 
Traditional Buddhist cosmology provides some context for such distinctions. Buddhists 
traditionally divide the world of beings into three realms, the realm of desire 
(kamadhatu), a more elevated realm of godly states (rupadhatu), and a realm of bodiless 
absorption states (arupadhatu). Each of these are still part of samsara. Embodied beings 
in the realm of desire include those suffering in hells, hungry ghosts, animals, humans, 
demi-gods and the gods. These different planes correspond to mental states (Trungpa, 
2002): hell represents suffering, hungry ghosts unsatisfied craving, animals are the 
embodiment of ignorance, demigods embody envy, and the gods are pleasure junkies.  
Humans, by contrast, have a mixture of all these mental states which makes a human 
mind the ideal form for spiritual development. Below the human realm beings are too 
distracted by torments, cravings and ignorance to develop morally and psychologically. 
Above the human realm the demigods and gods are too distracted by their striving and 
amusements.  Even the use of neurotechnologies to generate sublime, spiritual states of 
mind can be a trap. Advanced meditators are counseled to recognize experiences of 
absorption into oneness with all things or emptiness (arupa jhanas), as signs of 
meditative progress, but not as experiences to linger in.   
 
A distinctively Buddhist approach to the use of neurotechnologies would therefore seek 
to avoid being stuck in any one set of moods or mental states. Using a drug or nano-
neural device that created an addiction to a blessed out state of pleasure would be as 
unwholesome as making oneself as stupid as an animal, or as consumed with greed as a 
hungry ghost (e.g. addicted).  Buddhist psychology counsels that there is a difference 
between a dynamic eudaemonic happiness grounded in self-awareness and the constant 
stimulation of dopamine on a hedonic treadmill. 
 
This nuanced approach can be seen in the Western Buddhist discussion of psychedelics. 
Some Western Buddhists credit their experimentation with psychedelics with catalyzing 
their interest in meditation (Badiner, 2002), and providing an initial glimpse of their inner 
lives that they would not otherwise have had. There is even some evidence that 
psychedelics may have been incorporated into medieval Tantric Buddhist practice 
(Hajicek-Dobberstein, 1995), although they are certainly not used today. Few former 
psychedelic-using Buddhists believe that psychedelics changed their personality in the 
long-term however, and they recognize that habitual use of psychedelics would be very 
unhealthy (Redmond, 2004). 
 
Western Buddhists have also debated the use of antidepressants (Epstein, 1993; Hooper, 
1999) . Antidepressants are not true soma or happy pills, creating superior moods for 
everyone who takes them. At best they alleviate symptoms of depression for the severely 
depressed. The general conclusion is that clinical depression is very different from 
dukkha, the ubiquitous unsatisfactoriness of existence. Antidepressants are precisely the 
opposite of narcotics: they facilitate having sufficient energy and mental health to 
actually get on with life and a meditation practice (Bitner et al, 2003).   
 
Following this lead, Buddhists will likely be very concerned about the possibility that 
mood-modification may dull the mind and engender a static passivity towards oneself and 
others. But Buddhists will also be open to the possibility that safer, more powerful and 
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targeted mood-altering drugs and brain implants – “wire-heading” - may be useful in 
generating a positive, dynamic engagement with life. Evidence that our day-to-day level 
of subjective well-being, our “happiness set-point,” is about relatively stable across the 
life course and across situations, and about half genetically determined (Lykken, 1999; 
Weiss, 2008), suggests instead that mood could be boosted with only positive effects on 
our dynamic engagement.  
 
Happier people are more successful in achieving social, work and life goals. Happier 
people are more likely to get and stay married, have more friends, belong to more groups, 
and are more likely to volunteer. Happier people are more highly rated by their 
supervisors and they make more money. Happier people are also healthier and live longer 
(Lyubomirsky, King, and Diener, 2005; Oishi, Diener and Lucas, 2007; Walker, 2006).  
A gene therapy or drug which successful changed the happiness set-point to the setting 
that the happiest 1% of people thrive at, without tipping over into addiction or 
stupefaction, would presumably facilitate moral behavior and spiritual practice. 
 
 
Generosity and Loving-Kindness (Dana and Metta) 
  
The virtue of generosity is narrowly the willingness to share with others. Generosity 
requires overcoming greed and material attachment. But more broadly generosity is an 
exercise of empathy, compassion and loving-kindness, metta, the capacity to imagine 
others’ suffering as ones’ own and the active desire to help them. In this broader sense 
the exercise of dana and metta are the overcoming of self-absorption and neuroticism.  
 
The generation of compassion for all beings is one of the oldest meditation techniques in 
the Buddhist tradition, in which it is presented in several different forms. Research on 
people practicing a form of compassion visualization meditation has found it reduces 
stress hormones (Pace et al., 2008), and boosts positive emotions and well-being 
(Fredrickson et al., 2008; Pace et al., 2008) and feelings of social connectedness 
(Hutcherson et al., 2008).  
 
Many lines of research are suggesting that neurotechnologies to enhance generosity and 
compassion may also soon be possible. First, there is a strong genetic component to our 
innate predisposition for compassion and generosity.  The dominant model for the 
components of personality is the five factor model. The five factors are Openness, 
Conscientiousness, Extraversion, Agreeableness, and Neuroticism (OCEAN). The five 
factors have been statistically distilled from personality tests and appear to be stable over 
the life course. Each is about half genetically determined (Jang, Livesley and Vernon, 
1996; Bouchard and McGue, 2003), which suggests that drugs and gene therapies could 
be developed to change their personality attributes. Luo et al. (2007) has, for instance, 
found a number of genes correlated to these underlying personality dimensions. 
 
The factor of agreeableness appears to be particularly relevant to the virtues of generosity 
and compassion.  People who score high on agreeableness are more compassionate, 
trusting and helpful throughout their lives while people low in agreeableness will find it 
hard not to be uncooperative, unsympathetic and easily irritated regardless of how much 
they meditate and think loving thoughts. Agreeableness has been found to be correlated 
with empathy (del Barrio et al., 2004) and volunteering (Carlo et al., 2005). 
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Agreeableness is also related to several other personality constructs that have moral 
valence. Michael Ashton and colleagues (2005) have found that agreeableness is related 
to Honesty-Humility and Greed-Avoidance scales, which include personality descriptors 
such as sincere, fair, and unassuming as opposed to sly, greedy, and pretentious. 
Agreeableness and Honesty-Humility are in turn negatively associated with the ‘‘Dark 
Triad’’ traits of Machiavellianism, Narcissism, and Primary Psychopathy (Lee & Ashton, 
2005). 
 
Two examples of drugs that appear to boost agreeableness are oxytocin and MDMA. 
Oxytocin is a hormone released during romance, love making, child birth and breast-
feeding which induces feelings of trust and bonding. Its use is now being explored to 
overcome social phobia (shyness) and facilitate the social integration of people with 
autism (Baumgartner et al., 2008). Variations in oxytocin receptor genes are correlated 
with the ability to empathize with others’ feelings (Rodrigues et al., 2010), and oxytocin 
supplementation improves the ability to read social cues (Domes, 2007), trust in others 
(Kosfeld et al., 2005) and generosity in social games (Zak et al., 2007). MDMA or 
"ecstasy" is another drug whose users report feeling more love and compassion. Among 
other effects MDMA stimulates the release of oxytocin (Thompson et al., 2007).  
 
Self-Control, Renunciation and Honesty (Sila, Nekkhamma 
and Sacca) 
 
Self-discipline in Buddhism begins with the ability to keep the five ethical precepts, to 
refrain from killing, stealing, lying, intoxicants and sexual misconduct. But more 
generally sila and nekkhamma are the capacity to refrain from self-gratification, to be 
temperate in speech and deed. 
 
Here again we find that there is a substantial body of research suggesting that our 
capacity for self-discipline is genetically determined, and chemically malleable. The 
personality factor of conscientiousness is associated with carefulness, self-discipline, and 
thinking carefully before acting. Low conscientiousness is associated with substance 
abuse and criminality (Ozer & Benet-Martinez, 2006).  Conscientiousness appears to be 
associated in turn with genetic variations of the dopamine receptor (Blasi, 2009). 
Dopamine is the neurochemical that mediates the pleasure we receive from novel and 
risky activities such as gambling, drugs, alcohol and sex (Zald et al., 2008). Ben Zion et 
al. (2006) found that variations in the dopamine receptor gene is linked to lower or higher 
amounts of sexual desire. About 30% of humans have a variant that boosts sexual desire. 
Zietsch (2010) found a strong heritability of “risky sexual behavior” in a study of 5000 
twins.  
 
Another line of research has looked at the role of glucose availability in the brain and 
having the energy to resist temptation. Baumeister et al. (2007) found that the exercise of 
self-control depletes brain glucose, and with it the energy for self-control. Therapies that 
increase the brain’s supply of glucose would therefore boost self-discipline. 
 
Specific forms of compulsive behavior may be open to more targeted neurotechnological 
control. Sexual compulsion for instance is strongly influenced by testosterone, and the 
recidivism rate of sex offenders has been successfully reduced via chemical suppression 
of testosterone (Grubin, 2010). Although not a standard therapy, some clinicians are 
using testosterone suppression, antidepressants and other psychiatric drugs for “sex 
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addiction” or compulsive hypersexuality (Goodman, 2009). The neurochemical 
vasopressin has also been found to play an important role in sexual fidelity, facilitating 
the binding of the memory of sexual pleasure to a specific partner. Lim et al. (2004) 
found that modifying a vasopressin gene in prairie voles made males of a non-
monogamous species monogamous. Savulescu and Sandberg (2008) have suggested that 
the administration of oxytocin, vasopressin and testosterone might be useful as an adjunct 
to marital therapy in the future, rekindling sexual desire, deepening feelings of trust and 
mentally bonding partners to one another. 
 
As to the vice of gluttony, hundreds of thousands of people have undergone lap-band 
procedures to shrink the size of the stomach, and for most, their appetite for food. 
Patients are having electrical “pacemakers” implanted in their stomachs to tell the 
nervous system the stomach is full. Dozens of drugs are being researched to safely 
control appetite through the manipulation of the hormones involved in satiety, such as 
ghrelin and leptin (Hameed et al., 2008). Sibutramine, a drug which blocks the uptake of 
norepinephrine and serotonin, is in wide use as an appetite suppressant (although it has 
been removed from the market in Europe because of safety concerns.)  Lorcaserin, which 
acts on the brain’s cannabinoid receptors, is another appetite-suppressing drug close to 
approval in the United States.  
 
Patience and Equanimity (Kshanti and Upekkha)  
 
Our capacities for patience and equanimity appear to be similarly genetically and 
neurochemically determined. For instance a variety of mental health disorders have been 
found to be heritable. Tambs et al. (2009) studied twins and found that vulnerability to 
anxiety disorders was about 50% heritable.  
Our propensity towards anger and aggression  appears to be affected by variations in the 
monoamine oxidase A gene (MAOA). A third of people have a form of the MAOA gene 
which predisposes them to aggression in response to provocation (McDermott, 2009).    
 
The ability to rebound from traumatic life events without lasting effects on mental health 
is known as “resilience,” and research has also found resilience to be strongly heritable. 
Multiple studies have found genetic inheritability for risks of stress, depression and 
schizophrenia. Beaver et al. (2010) found psychological resilience from victimization to 
be related to variations of genes that determine dopamine and serotonin. Variations in the 
corticosteroid regulating genes are linked to our susceptibility to stress (DeRijka, 2008). 
The OCEAN personality trait of Neuroticism is also highly heritable, a major risk factor 
for clinical depression (Kendler, 2010). 
 
 
 
Effort, Perseverance, and Concentration (Virya, Adhitthana 
and Dhyana)  
 
One piece of evidence for the neurobiological basis of our capacity for diligence and 
concentration is found in attention deficit disorder. Twin studies and studies of parents 
and children show that ADHD is strongly heritable, and appears to linked to variations of 
the dopamine and serotonin regulating genes (Faraone et al., 2010). While clinical 
ADHD is only present in 5-10% of the population, the underlying attentional mechanisms 
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presumably vary across the population, with outliers at the other end exhibiting very high 
capacities for focus, persistence and self-control. Andrew Fenton’s (2009) essay on a 
Buddhist approach to the use of methylphenidate has already advanced the argument that 
drugs could facilitate meditative practice and general mindfulness in daily life. A goal of 
Buddhist moral enhancement in general would be to develop means for the average 
person bring their full attention to every situation. An even stronger case could be made 
for the drug modafanil, which, unlikely methylphenidate, improves wakefulness and task 
performance in most subjects, and without the stimulants side effects and risks of 
dependency. Greeley et al. (2008) and others have begun to argue that these cognitive 
enhancement drugs are so safe and beneficial that they should be deregulated. 
 
The ability to keep returning to task is likewise a desirable virtue, and one that appears to 
have a neurogenetic component. In a study of twins Tony Vernon and his team at the 
University Western Ontario (Horsburgh et al., 2009) found that half of the variation in the 
capacities for commitment, confidence and the ability to face new challenges were 
genetically determined. More disturbingly Vialou et al. (2010) subjected rats to days of 
electrical shocks from the wire mesh whenever they attempted to leave their cages. They 
found that rats that had been engineered to overexpress the chemical ΔFosB in their 
reward circuits of the nucleus accumbens were more likely to continue trying to escape, 
while rats engineered with low levels of ΔFosB gave up. They speculate that 
supplementing this brain chemical in humans might increase resilience to stress and 
determination in the face of challenges.  
 
Wisdom (Prajna Paramita)  
 
Meditation-oriented Buddhism has tended to downplay the discursive, intellectual aspect 
of the concept of prajna, and to emphasize non-discursive awareness. But the Buddhist 
canon is clear that prajna is a combination of discursive, intellectual analysis with the 
mental clarity of a concentrated and spacious mind. Prajna is the capacity to see the true 
nature of things, their causal connections, and how things constantly change.  Prajna 
requires an openness to new ideas and experiences, and the ability to recognize and avoid 
cognitive biases, habits of mind that lead us to false conclusions. Prajna requires general 
intelligence, and the more the better. 
 
Again there is substantial evidence for genes that influence our cognitive abilities. For 
instance, Haworth et al. (2009) found 50% of the variation of intelligence (“g”) to be 
genetic in a study of in 11,000 twins in Australia, the Netherlands, the United Kingdom 
and the United States. Many neuro-geneticists believe that genetic enhancement for 
intelligence is unlikely because of the number of genes involved. But if half a dozen of 
the most potent intelligence genes, or their neurochemistries, were targeted for 
enhancement that would presumably have a dramatic effect. 
 
Drugs are now being investigated to enhance a number of cognitive abilities, largely as 
therapies for neurological conditions such as Alzheimers and Downs syndrome. A great 
deal of attention has focused on the ability of the brain to generate neural stem cells to 
repair brain damage, and to find drugs and gene therapies which can enhance the plastic 
and reparative capacity of the brain. Sugiyama et al. (2009) have found for instance that 
neural plasticity is controlled by the Otx2 protein, which may be a potential therapy for 
ramping up brain repair. Two other intriguingly futuristic avenues of this research are the 
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electrical stimulation of neural tissue, and the use of nanomaterials are scaffolds for the 
regeneration of neural connections. 
  
Conclusion 
 
Future neurotechnologies will include drugs, implanted devices and gene therapies that 
target specific moods, cognitions, impulses and behaviors. From a Buddhist perspective 
the growing ability to control our behavior will be an opportunity to suppress unskillful 
impulses and behaviors, and enhance our practice of the virtues. Mental illness and more 
routine emotional lability can be smoothed out, and mood ramped up to an optimal level 
of high, dynamic well-being. Neurotechnologies will at first be relied on as temporary 
spiritual training wheels, helping to create a solid foundation of moral behavior, 
concentration and mental clarity as part of the practice of self-reflection and meditation. 
As the technologies develop they may be used as the principal means of self-
transformation. The Buddhist rejection of the idea of an essential core self and emphasis 
on self-transformation will likely become more attractive as personalities become more 
malleable. 
 
At the same time the growing ability to modify mood and induce states of blissful 
absorption will pose a growing risk of addiction and stasis. The Buddhist goal of a more 
engaged, compassionate, form of eudaemonic happiness will become increasingly 
relevant as a alternative to the growing temptation of wireheading and chemical bliss. 
Buddhism can offer a model of cognitive enhancement that points past the tarpits to 
liberation. 
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